Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
FDA Small Scientific Conference Grant Program (R13)
The FDA recognizes the value of supporting high quality, small scientific conferences.
A small scientific conference is defined as a symposium, seminar, workshop, or any formal meeting, whether conducted face-to-face or virtually to exchange information and explore a defined subject, issue, or area of concern impacting the public's health within the scope of the FDA's mission.
Support of such meetings is contingent upon the fiscal and programmatic interests and priorities of the FDA's respective Offices and Centers.
Therefore, each small scientific conference grant application must contain a cover letter.
The cover letter must clearly state the primary objectives of the meeting, anticipated outcomes, and the FDA Office/Center that the application should be forwarded to for consideration.
If the stated objectives and anticipated outcomes are not consistent with the mission and current program priorities of the targeted FDA Office/Center the application will not be forwarded for review.
Failure to identify an Office/Center in the cover letter will disqualify an application.
For more information about the FDA and its respective Offices and Centers, visit www.fda.gov.
A small scientific conference is defined as a symposium, seminar, workshop, or any formal meeting, whether conducted face-to-face or virtually to exchange information and explore a defined subject, issue, or area of concern impacting the public's health within the scope of the FDA's mission.
Support of such meetings is contingent upon the fiscal and programmatic interests and priorities of the FDA's respective Offices and Centers.
Therefore, each small scientific conference grant application must contain a cover letter.
The cover letter must clearly state the primary objectives of the meeting, anticipated outcomes, and the FDA Office/Center that the application should be forwarded to for consideration.
If the stated objectives and anticipated outcomes are not consistent with the mission and current program priorities of the targeted FDA Office/Center the application will not be forwarded for review.
Failure to identify an Office/Center in the cover letter will disqualify an application.
For more information about the FDA and its respective Offices and Centers, visit www.fda.gov.
Who's Eligible
Obtain Full Opportunity Text:
NIH Guide for Grants and Contracts
Additional Information of Eligibility:
To be eligible for funding under this APS, applications must propose people-to-people programs as described in Section A.1 above.
Potential partners include but are not necessarily limited to: private voluntary organizations, foundations, colleges and universities, civic groups, faith-based and community institutions, international organizations, private businesses and associations, regional organizations, philanthropic organizations, and advocacy groups.
For-profit applicants should note that USAID policy prohibits the payment of fee/profit to the prime recipient under grants and cooperative agreements.
Forgone profit does not qualify as cost-sharing or leveraging.
USAID encourages applications from potential new partners.
I.
Types and Nationalities of NGOs 1.
U. S. and Non-U. S. Non-Profit Organizations Qualified U. S. and non-U. S. private non-profit organizations may apply for USAID funding under this APS.
Foreign government-owned parastatal organizations from countries that are ineligible for assistance under the FAA or related appropriations acts are ineligible.
2.
U. S. and Non-U. S. For-Profit Organizations Potential for-profit applicants should note that, pursuant to 22 CFR 226.81, the payment of fee/profit to the prime recipient under grants and cooperative agreements is prohibited.
Forgone profit does not qualify as cost-sharing or leveraging.
However, if a prime recipient has a (sub)-contract with a for-profit organization for the acquisition of goods or services (i.e., if a buyer-seller relationship is created), fee/profit for the (sub)-contractor is authorized.
3.
U. S. and Non-U. S. Colleges and Universities Qualified U. S. and non-U. S. colleges and universities may apply for funding under this APS.
USG and USAID regulations generally treat colleges and universities as NGOs, rather than governmental organizations; hence, both public and private colleges and universities are eligible.
Non-U. S. colleges and universities in countries that are ineligible for assistance under the FAA or related appropriations acts are ineligible.
II.
Private Voluntary Organization (PVO) A local or indigenous PVO, which by definition is a non-U. S. PVO operating in the same foreign country in which it is organized, that is not already registered with USAID is eligible to receive funding.
However, such organizations are encouraged to consider registration.
In accordance with 2 CFR 203, U. S. PVO or an “International PVO'', which by definition is a non-U. S. PVO that performs development work in one or more countries other than the country in which it is domiciled, must be registered with USAID to be eligible to receive funding.
III.
Public International Organizations (PIOs) PIOs are eligible to apply for funding under this APS.
Please see Automated Directives Series (ADS) 308 for USAID policy on defining PIOs.
http://www.usaid.gov/sites/default/files/documents/1868/308.pdf USAID encourages applications from partnerships or consortia directed by or including local organizations.
In this context, partnerships are defined as a negotiated arrangement among organizations that provides for a substantive, collaborative role for each of the partners in the planning and implementation of the project.
Applicants intending to represent a coalition of providers should be prepared to provide, if requested, a signed partnership agreement stating: • An intent to commit or receive resources from the prospective partner(s) contingent upon receipt of funds; • How the partnership arrangement advances the objectives of the program; • Supporting documentation identifying the resources, experience, and expertise of the partner(s); • Evidence that the partner(s) has been involved in the planning of the project; and • Clarification of the role of the partner(s) in the implementation of the program, evaluation, and sustainability.
Full Opportunity Web Address:
Contact:
Agency Email Description:
Agency Email:
Martin.Bernard@fda.hhs.gov
Date Posted:
2011-09-14
Application Due Date:
2014-06-10
Archive Date:
2014-06-12
Social Entrepreneurship
Spotlight
Is Corporate Philanthropy Dead?
Senay Ataselim-Yilmaz, Chief Operating Officer, Turkish Philanthropy Funds, writes that philanthropy often solves the very problems that stems from market failure. Some social issues, however, cannot be tackled by questioning the return on investment.
Learn How to Identify and Avoid Grant Scams
